Results 291 to 300 of about 850,997 (356)
Robotic Distal Pancreatectomy for Adult Pancreatoblastoma with Tumor Extension to the Main Pancreatic Duct: A Case Report. [PDF]
Sugita H +12 more
europepmc +1 more source
ABSTRACT Background This study aimed to evaluate the outcomes of patients with unresectable cholangiocarcinoma (CCA) who underwent portal vein embolization (PVE) with a focus on overall survival (OS) and the frequency of biliary drainage (BD). Methods In this retrospective analysis, we evaluated 255 patients with unresectable CCA; 56 patients underwent
Ho Seung Lee +8 more
wiley +1 more source
ABSTRACT Background/Purpose A standardized liver parenchymal transection method in robotic‐assisted liver resection has not yet been established, and the techniques used vary among institutions. We developed a novel transection technique for robotic‐assisted liver resection termed “Trac & Pac,” which uses maryland bipolar forceps with a gentle stroking
Yuta Abe +8 more
wiley +1 more source
Unclassifiable Congenital Biliary Dilatation With a Meandering Main Pancreatic Duct and Suspected Pancreaticobiliary Maljunction. [PDF]
Shim Y +4 more
europepmc +1 more source
ABSTRACT Background Congenital biliary dilatation (CBD) is a rare anomaly often treated surgically, yet postoperative complications remain a concern. This study aimed to evaluate the incidence, timing, and risk factors of such complications after CBD surgery.
Takuya Maeda +9 more
wiley +1 more source
Efficacy and safety of early pancreatic duct stenting for unresectable pancreatic cancer: A randomized controlled trial. [PDF]
Sun MH +4 more
europepmc +1 more source
ABSTRACT Purpose There has been little discussion on the differences in characteristics and long‐term outcomes of congenital biliary dilation (CBD) by age group. Methods We conducted a regional multicenter study to investigate all pediatric cases of CBD in the Kyushu area of Japan over the past decade.
Masakazu Murakami +15 more
wiley +1 more source
ABSTRACT The indications for liver transplantation continue to expand to meet the growing need of patients with end‐stage liver disease and select hepatic malignancies. Living donor liver transplantation allows for access to transplant with recipient outcomes superior to deceased donor liver transplantation.
Anum Aslam +8 more
wiley +1 more source

